Presynaptic α2δs specify synaptic gain, not synaptogenesis, in the mammalian brain
Neuron · 2025
DOI: 10.1016/j.neuron.2025.04.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2025. Verfasst von William Milanick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gene Therapy Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA; Interdisciplinary Graduate Program in Neuroscience, Univer…. Hauptthemen laut MEDLINE: Synapses, Presynaptic Terminals, Calcium Channels, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS, NINDS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The α2δs are a family of extracellular synaptic molecules that are auxiliary subunits of voltage-gated Ca2+ channel (CaV) complexes. They are linked to brain disorders and are drug targets. The α2δs are implicated in controlling synapse development and function through distinct CaV-dependent and CaV-independent pathways. However, the mechanisms of action remain enigmatic since synapses contain mixtures of α2δ isoforms in the pre- and postsynaptic compartments. We developed a triple conditional knockout mouse model and demonstrated the combined selective presynaptic ablation of α2δs in vivo in a developing mammalian glutamatergic synapse. We identified presynaptic α2δs as positive regulators of Munc13-1 levels, an essential neurotransmitter release protein. We found that mammalian synapse development, presynaptic CaV2.1 organization, and the transsynaptic alignment of presynaptic release sites and postsynaptic glutamate receptors are independent of presynaptic α2δs. Therefore, our results define presynaptic α2δ regulatory roles and suggest a new α2δ role in controlling synaptic strength and plasticity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gene Therapy Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA; Interdisciplinary Graduate Program in Neuroscience, University of Iowa, Iowa City, IA 52242, USA.
- Gene Therapy Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA.
- The Imaging Center and Electron Microscopy Core Facility, Max Planck Institute for Neuroscience, Jupiter, FL 33458, USA.
- Gene Therapy Center, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA; Department of Pediatrics, Department of Pharmacology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA. Elec…
Förderung
- NIDCD NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
- National Institute on Deafness and Other Communication Disorders
- University of Iowa
- National Institute of Neurological Disorders and Stroke
- The University of North Carolina at Chapel Hill
Zitieren
APA
Milanick, W., Li, J., Thomas, C. I., Al-Yaari, M., Guerrero-Given, D., Kamasawa, N., & Young, S. M. (2025). Presynaptic α2δs specify synaptic gain, not synaptogenesis, in the mammalian brain. Neuron. https://doi.org/10.1016/j.neuron.2025.04.013
Vancouver
Milanick W, Li J, Thomas CI, Al-Yaari M, Guerrero-Given D, Kamasawa N, et al. Presynaptic α2δs specify synaptic gain, not synaptogenesis, in the mammalian brain. Neuron. 2025. doi:10.1016/j.neuron.2025.04.013
BibTeX
@article{Milanick2025,
author = {Milanick, William and Li, Jianing and Thomas, Connon I and Al-Yaari, Mohammed and Guerrero-Given, Debbie and Kamasawa, Naomi and Young, Samuel M},
title = {Presynaptic α2δs specify synaptic gain, not synaptogenesis, in the mammalian brain},
journal = {Neuron},
year = {2025},
doi = {10.1016/j.neuron.2025.04.013}
}
EUVIMED